Identification of costimulatory molecule signatures for evaluating prognostic risk in non-small cell lung cancer

Background: Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality worldwide. Despite advances in treatment, prognosis remains poor, necessitating the identification of reliable prognostic biomarkers. Costimulatory molecules (CMs) have shown to enhance antitumor immune res...

Full description

Bibliographic Details

Published in:	Heliyon
Main Authors:	Yan Yang, Suqiong Lu, Guomin Gu
Format:	Article
Language:	English
Published:	Elsevier 2024-09-01
Subjects:	Non-small cell lung cancer Costimulatory molecule Prognosis Immunotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024128472